Delflex Peritoneal Dialysis Solution In Biofine Container 1.5% Dextrose shortage — US supply status & alternatives

Delflex Peritoneal Dialysis Solution In Biofine Container 1.5% Dextrose

—

In supply · Australia

DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Delflex Peritoneal Dialysis Solution In Biofine Container 1.5% Dextrose
Brand names	DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in
Therapeutic category	Auto-created by FDA MedWatch — Drug Safety Alerts scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 20h ago

High

Recalls official enforcement reports

🇺🇸

Delflex Peritoneal Dialysis Solution With

Fresenius Medical Care Holdings, Inc. · Apr 2021

Class IIIdetails ↗

Verified timeline regulator events

🇺🇸 6 Apr 2026

high reported

🇺🇸 18 June 2024

high reported

🇺🇸 28 Dec 2023

high reported

Sources official regulators

🇺🇸

FDA MedWatch

verified 20h ago

verify ↗

Mederti Drug Report

Generated 5 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.